Impact of hospitalization for vaso‐occlusive crisis on health‐related quality of life in children with sickle cell disease
Pediatric Blood & Cancer · 2023-12 · 70 (12)
DOI: 10.1002/pbc.30691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 25.09.2023. Verfasst von Caroline Vuong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Amsterdam UMC - Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Anemia, Sickle Cell, Hospitalization, Vascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is characterized by vaso‐occlusive crises (VOCs) that impair the health‐related quality of life (HRQoL). The aim of this study is to evaluate the impact of hospitalization for VOCs on HRQoL in children with SCD over time.
Methods
In this longitudinal cohort study, children aged 8–18 years diagnosed with SCD at the Amsterdam UMC were included between 2012 and 2021. HRQoL was annually measured as part of standard care using the Pediatric Quality of Life Inventory. The impact of hospitalization for VOC on HRQoL was evaluated using linear mixed models 3, 6, 9, and 12 months after hospitalization. The effect of frequency of hospitalization for VOC on HRQoL was evaluated over the last 12 months.
Results
In total, 94 children with SCD were included with a median age of 11.8 years (interquartile range [IQR]: 9–14). Thirty‐seven patients (39%) had been hospitalized for a VOC. Hospitalization for VOC led to a decrease of 3.2–4.8 points in total HRQoL compared to patients without hospitalization, most pronounced 3 months after hospitalization. Recurrent admission for VOC in the last 12 months was associated with a decrease of 2.3 points in total HRQoL ( p = .04). The most affected subscale was physical functioning.
Conclusion
The adverse effects of hospitalization for VOC in children with SCD persist up to 12 months after hospitalization. After hospitalization for VOC, extra attention and support for its negative impact on HRQoL are recommended. This study also underlines the importance of systematically measuring HRQoL, allowing clinicians to intervene accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology, Amsterdam UMC - Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands.
- Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC - Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands.
- Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
ORCID-Profile: Caroline Vuong
Zitieren
APA
Vuong, C., Moussa, I., van Muilekom, M. M., Heijboer, H., Rettenbacher, E., Haverman, L., Twisk, J., Fijnvandraat, K., & Eckhardt, C. L. (2023). Impact of hospitalization for vaso‐occlusive crisis on health‐related quality of life in children with sickle cell disease. Pediatric Blood & Cancer, 70(12). https://doi.org/10.1002/pbc.30691
Vancouver
Vuong C, Moussa I, van Muilekom MM, Heijboer H, Rettenbacher E, Haverman L, et al. Impact of hospitalization for vaso‐occlusive crisis on health‐related quality of life in children with sickle cell disease. Pediatric Blood & Cancer. 2023;70(12). doi:10.1002/pbc.30691
BibTeX
@article{Vuong2023,
author = {Vuong, Caroline and Moussa, Ibtissame and van Muilekom, Maud M and Heijboer, Harriët and Rettenbacher, Eva and Haverman, Lotte and Twisk, Jos and Fijnvandraat, Karin and Eckhardt, Corien L},
title = {Impact of hospitalization for vaso‐occlusive crisis on health‐related quality of life in children with sickle cell disease},
journal = {Pediatric Blood & Cancer},
year = {2023},
volume = {70},
number = {12},
doi = {10.1002/pbc.30691}
}
EUVIMED